IKZF1 and acute lymphoblastic leukemia: Notably, studies affirm that the loss or malfunction of IKZF1 is closely linked to drug resistance, heightened relapse rates, and unfavorable prognosis in acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) (30–32).